Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment of multidrug-resistant or rifampicin-resistant tuberculosis with an all-oral 9-month regimen containing linezolid or ethionamide in South Africa: A retrospective cohort study.
Morgan H, Ndjeka N, Hasan T, Gegia M, Mirzayev F, Nguyen L, Schumacher S, Schlub TE, Naidoo K, Fox GJ. Morgan H, et al. Among authors: mirzayev f. Clin Infect Dis. 2024 Mar 25:ciae145. doi: 10.1093/cid/ciae145. Online ahead of print. Clin Infect Dis. 2024. PMID: 38525535
Multidrug-resistant tuberculosis.
Dheda K, Mirzayev F, Cirillo DM, Udwadia Z, Dooley KE, Chang KC, Omar SV, Reuter A, Perumal T, Horsburgh CR Jr, Murray M, Lange C. Dheda K, et al. Among authors: mirzayev f. Nat Rev Dis Primers. 2024 Mar 24;10(1):22. doi: 10.1038/s41572-024-00504-2. Nat Rev Dis Primers. 2024. PMID: 38523140 Review.
The Safety and Tolerability of Linezolid in Novel Short-Course Regimens Containing Bedaquiline, Pretomanid, and Linezolid to Treat Rifampicin-Resistant Tuberculosis: An Individual Patient Data Meta-analysis.
Hasan T, Medcalf E, Nyang'wa BT, Egizi E, Berry C, Dodd M, Foraida S, Gegia M, Li M, Mirzayev F, Morgan H, Motta I, Nguyen L, Schumacher S, Schlub T, Fox G. Hasan T, et al. Among authors: mirzayev f. Clin Infect Dis. 2024 Mar 20;78(3):730-741. doi: 10.1093/cid/ciad653. Clin Infect Dis. 2024. PMID: 37874021 Free PMC article. Review.
Lifesaving, cost-saving: Innovative simplified regimens for drug-resistant tuberculosis.
Gupta A, Juneja S, Sahu S, Yassin M, Brigden G, Wandwalo E, Rane S, Mirzayev F, Zignol M. Gupta A, et al. Among authors: mirzayev f. PLOS Glob Public Health. 2022 Nov 16;2(11):e0001287. doi: 10.1371/journal.pgph.0001287. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962626 Free PMC article. No abstract available.
Co-administration of treatment for drug-resistant TB and hepatitis C.
Olaru ID, Beliz Meier M, Schumacher SG, Prodanovic N, Kitchen PJ, Mirzayev F, Denkinger CM. Olaru ID, et al. Among authors: mirzayev f. Int J Tuberc Lung Dis. 2023 Jan 1;27(1):66-68. doi: 10.5588/ijtld.22.0403. Int J Tuberc Lung Dis. 2023. PMID: 36853135 Free PMC article. No abstract available.
Bridging the gap: key evidence needed to strengthen global policies to end TB.
Gebreselassie N, Falzon D, Zignol M, Viney K, Ismail N, Mirzayev F, Mavhunga F, Kasaeva T. Gebreselassie N, et al. Among authors: mirzayev f. Int J Tuberc Lung Dis. 2022 Aug 1;26(8):704-707. doi: 10.5588/ijtld.22.0153. Int J Tuberc Lung Dis. 2022. PMID: 35898130 No abstract available.
31 results